Expanding Your Practice: Design and Implementation of Ototoxicity Monitoring Programs (.3 CEUS/Tier 1)
Recorded On: 08/15/2018
Expanding Your Practice: Design and Implementation of Ototoxicity Monitoring Programs
August 15, 2018, 12 pm- 3 pm ET
Presenters: Dawn Konrad-Martin, PhD; Angie Garinis, PhD; Jaclyn Schurman, AuD
Duration: 3 hours
Instructional Level: Intermediate
Program Focus: Knowledge
Learner Outcomes: Upon completions, each participant in the eAudiology Web Seminar will be able to:
- List the most common ototoxic medications.
- Describe monitoring protocols for adult and pediatric patients.
- Discuss techniques for implementing ototoxicity monitoring programs in their own clinics.
Description: Ototoxic medications are typically used as therapeutics for potentially life-threatening illnesses and are prescribed by physicians who may not be familiar with the detrimental effects that hearing loss can have on patients’ ability to communicate and, ultimately, quality of life. Clinical practice guidelines have been developed to outline what audiologic tests are necessary, how often they should be utilized, and what changes in hearing are considered actionable. The implementation of these protocols into busy audiology clinics require certain considerations in order to be successful: familiarity with common terminology in these diseases and disorders, how to best advertise available services to and communicate with treatment care physicians, and how to efficiently provide the most effective monitoring techniques. These presenters will cover these topics and help to provide audiologists with the most up-to-date information on successful implementation techniques for adult and pediatric/neonate patients. With this information, audiologists can expand their services to meet the needs of patients, treatment care providers, and the audiologists’ clinics, alike.
Dr. Dawn Konrad-Martin is a Research Investigator at VA National Center for Auditory Rehabilitation Research (NCRAR), and Associate Professor in the Department of Otolaryngology/Head and Neck Surgery at Oregon Health & Science University. She received a PhD in audiology from the University of Washington investigating peripheral auditory function in mouse and gerbil models of auditory system development, and conducted a post-doctoral fellowship at BoysTown National Research Hospital examining otoacoustic emissions in relation to normal and impaired auditory function. Her research seeks to identify pathophysiologic changes in the peripheral auditory system associated with common forms of acquired hearing loss. She uses electrophysiology and otoacoustic emissions to benchmark normal age-related auditory system changes, and to characterize trajectory differences caused by diabetes, ototoxicity, and more recently, noise overexposure. Her projects are highly collaborative, involving researchers who conduct animal studies, and who are experts in psychophysics or speech perception. Dr. Konrad-Martin has held leadership roles with the American Speech-Language and Hearing Association (ASHA), including being elected Assistant Coordinator of Steering Committee, ASHA Special Interest Division 6: Hearing and Hearing Disorders, Research and Diagnostics, and being appointed to the Research and Scientific Affairs Committee. She served on a workshop panel focused on noise-induced cochlear synaptopathy for the National Institutes on Deafness and Other Communication Disorders at the National Institutes of Health (NIDCD/NIH), served on a committee to develop multi-disciplinary, evidence-based guideline to promote translation from basic research activities through clinical trials for the Department of Defense (DoD) Hearing Center of Excellence (HCE), and currently serves on the DoD HCE committee on ototoxicity.
Dr. Angela Garinis
Dr. Angela Garinis has a joint research appointment at Oregon Health & Science University and the VA Portland Health Care System's National Center for Rehabilitative Auditory Research (NCRAR). Dr. Garinis received her clinical audiology degree in 2003 and a PhD in Speech & Hearing Sciences in 2008 at the University of Arizona in Tucson. She completed a three-year NIH funded Postdoctoral fellowship at the University of Washington in Dr. Lynne Werner's Infant Psychoacoustics Laboratory (2008-2011). Her primary research interests involve improving non-invasive techniques for the diagnoses of middle-ear and/or cochlear dysfunction. She also has a strong interest in the diagnoses and monitoring of ototoxic hearing loss in patients receiving aminoglycoside treatments. Dr. Garinis is currently funded by NIH-NIDCD to investigate the effects of aminoglycoside antibiotics on the efferent auditory system of patients with cystic fibrosis.
Dr. Jaclyn Schurman
Dr. Jaclyn Schurman received her Au.D. from the University of Maryland and is currently a research audiologist at Walter Reed National Military Medical Center in Bethesda, MD. Her research has been focused on the use of mobile hearing assessment technology and the evaluation of patients using realistic listening scenarios.